Callan JMB Inc. Receives Nasdaq Deficiency Letter Regarding Stockholders' Equity

Callan JMB Inc. received a deficiency letter from Nasdaq on April 7, 2026, indicating non-compliance with the minimum stockholders' equity requirement of $2,500,000 for continued listing on The Nasdaq Capital Market. The company has been granted an initial period of 45 days, until May 22, 2026, to submit a plan to regain compliance. If the plan is accepted, Nasdaq may grant up to 180 additional days, until October 4, 2026, to demonstrate compliance. While the notice does not immediately affect the trading of the company's common stock under the symbol "CJMB," there is no assurance that the submitted plan will be accepted or that the company will ultimately regain compliance. The filing also includes forward-looking statements regarding the company's intentions and ability to regain compliance, subject to various risks and uncertainties.